| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |